Creative Planning’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Creative Planning’s Portfolio CSCI Stock Details CSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-100	Closed	-$30K	–	2125
2019 Q2	$30K	Buy	+100	New	+$35.3K	﹤0.01%	1859
2017 Q2	–	Sell	-20	Closed	-$6K	–	4866
2017 Q1	$6K	Hold	20	–	–	﹤0.01%	3896
2016 Q4	$7K	Sell	20 -30	-60%	-$11.2K	﹤0.01%	3794
2016 Q3	$17K	Buy	+50	New	+$17.5K	﹤0.01%	3178
2016 Q2	–	Hold	0	–	–	–	4553
2016 Q1	–	Sell	-9	Closed	-$2.97K	–	4564
2015 Q4	$4K	Sell	9 -11	-55%	-$6.91K	﹤0.01%	3813
2015 Q3	$18K	Buy	20 +10	+100%	+$14.6K	﹤0.01%	2820
2015 Q2	$28K	Buy	+10	New	+$42.1K	﹤0.01%	1056
2013 Q4	–	Hold	0	–	-$1K	–	3495
2013 Q3	–	Hold	0	–	–	–	3127
2013 Q2	–	Hold	0	–	–	–	2854

Other funds holding CSCI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return

Creative Planning's CSCI Position: Q3 2019 in Review

Creative Planning sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2019, closing a stake of 100 shares — an estimated $30K sold.

Creative Planning first reported a position in CSCI in Q2 2015 and held it in 7 quarters. The position peaked at $30K in Q2 2019. 26 funds tracked by Wall St. Rank hold CSCI as of Q3 2019.

Creative Planning reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
Creative Planning sold 100 COSCIENS Biopharma Inc. Common Stock shares in Q3 2019, an estimated $30K.
Creative Planning first reported a position in COSCIENS Biopharma Inc. Common Stock in Q2 2015 and held it in 7 quarters.
Creative Planning's COSCIENS Biopharma Inc. Common Stock position peaked at $30K in Q2 2019.
26 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2019.

Based on Creative Planning's 13F filing for Q3 2019, filed 1 Nov 2019.